MedTrace Logo

Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation

NCT05940584 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2024-12-09

No results posted yet for this study

Summary

The goal of this three-armed, observer-blinded, randomised controlled trial is to (i) to implement a telerehabilitation intervention in routine care after an inpatient rehabilitation stay for people insured with the Social Insurance Institution for the Self-Employed (SVS), (ii) to evaluate the impact of telerehabilitation on the consolidation of goals achieved during the inpatient stay in everyday life, and (iii) to evaluate whether independence in everyday life can be increased by implementing telerehabilitation at home compared to standard care. Our hypothesis is that the tele-reha intervention, including ongoing therapist support, will improve independence in daily living (defined as the primary outcome of this study), as measured by the Functional Assessment Measure (FAM), compared to a control group receiving a standard paper-based program.

Conditions

  • Neurologic Disorder

Interventions

DEVICE

Tele-Reha provided with EvoPads

Exercises and cognitive training provided on an EvoPad

OTHER

Paper-based exercises with option to do tele-reha afterwards

Similar exercises and cognitive training as Group 1 provided on paper. Patients receive the Tele-Reha afterwards

OTHER

Only paper-based exercises

Same exercises and cognitive training as Group 2 provided on paper only.

Sponsors & Collaborators

  • Neurologisches Rehabiliationszentrum Rosenhügel

    collaborator OTHER

  • Medical University of Vienna

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-14
Primary Completion
2025-01-01
Completion
2025-01-14

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940584 on ClinicalTrials.gov